RETRACTED ARTICLE: LINC01224 Exhibits Cancer-Promoting Activity in Epithelial Ovarian Cancer Through microRNA-485-5p-Mediated PAK4 Upregulation

Abstract

Xing S, Zhang Y, Zhang J. Onco Targets Ther. 2020;13:5643–5655.

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised over alleged image duplication in Figure 6B with a similar image from an unrelated article, specifically:

• Figure 6B appears to have been duplicated with a similar image in Figure 7B from Qin et al, 2020 (https://doi.org/10.3727/096504020X15928179818438).

The authors responded to our initial queries but were unable to provide a satisfactory explanation for the alleged duplication and could not provide satisfactory original data for their study. The Editor advised for the article to be retracted.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Keywords:

• long intergenic non-protein coding RNA 1224
• p21‑activated kinase 4
• epithelial ovarian cancer
• anticancer therapy

View retraction statement:

LINC01224 Exhibits Cancer-Promoting Activity in Epithelial Ovarian Cancer Through microRNA-485-5p-Mediated PAK4 Upregulation [Retraction]